Document is current
Any future updates will be listed below
-
Authors
Weber, Michel
Parmeggiani, Francesco
Bremond-Gignac, Dominique
Daly, Avril
Lahaye, Marjolein
Lotery, Andrew
Paudel, Nabin
Ritter, Markus
de la Rúa, Enrique Rodríguez
Rotenstreich, Ygal
Sankila, Eeva-Marja
Stingl, Katarina
Van Denderen, Jacqueline
Denee, Tom
Pungor, Katalin https://orcid.org/0000-0003-4679-2050
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals NV
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 1 April 2025
First Online: 29 April 2025
Declarations
:
: Michel Weber, Andrew Lotery, Markus Ritter and Enrique Rodríguez de la Rúa have received consulting fees from Janssen and Novartis. Francesco Parmeggiani has received consulting fees from AbbVie, Bayer, Janssen, Novartis and Roche. Dominique Bremond-Gignac has received consulting fees from Alcon, Janssen, Novartis, Santen and Thea. Avril Daly, Nabin Paudel and Eeva-Marja Sankila have no competing interests. Ygal Rotenstreich has received a consulting fee from Janssen. Katarina Stingl has received consulting fees to the University from Janssen, Novartis, ProQR Therapeutics, Santen, and ViGeneron. Marjolein Lahaye, Jacqueline Van Denderen, Tom Denee, and Katalin Pungor are employees of Johnson and Johnson.
: The study received local ethical committee approval at each study site (Austria, Ethik Komission Medizinische Universität Wien: 1088/2022; Belgium, Ethics Committee Research UZ/UK Leuven: B3222022000832; UK, Health Research Authority Integrated Research Application System: 307690; Finland, HUSin Alueellinen Lääketieteellinen Tutkimuseettinen Toimikunta: 48/2022; France, Comité de Protection des Personnes Nord Ouest IV: 22.02349.000114; Germany, EC Medical Faculty of Eberhard-Karls-University and University Clinic Tübingen: 839/2021BO1, 2022-200343-BO-bet; Israel, EC of the Chaim Cheba Medical Centre: 9186-22-SMC; Israel, EC of the Soroka Medical Center: 0391-21-SOR; Italy, Comitato Ethico di Area Vasta Emilia Centro: 1026/2021/Oss/AOUFe; The Netherlands, Dutch Clinical Research Foundation: 21.177/VS; Spain, Comité de Ética de la Investigación con medicamentos Euskadi: PI2022051) (see Supplementary Table S2 for more details) and adhered to the tenets of the Declaration of Helsinki. All participants gave informed consent.
